Lichen International Limited
LICN
$3.53
$0.3711.71%
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 24.86% | 21.22% | 17.61% | 9.03% | 0.37% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 24.86% | 21.22% | 17.61% | 9.03% | 0.37% |
| Cost of Revenue | 17.95% | 15.71% | 13.41% | 6.90% | 0.53% |
| Gross Profit | 29.78% | 25.04% | 20.44% | 10.51% | 0.26% |
| SG&A Expenses | 20.72% | 23.24% | 26.37% | 27.96% | 29.62% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.23% | 19.00% | 18.75% | 15.43% | 12.09% |
| Operating Income | 43.69% | 27.15% | 15.13% | -5.01% | -25.64% |
| Income Before Tax | 61.18% | 28.82% | 7.88% | -13.74% | -35.35% |
| Income Tax Expenses | 64.01% | 33.28% | 11.15% | -6.93% | -25.61% |
| Earnings from Continuing Operations | 59.95% | 27.04% | 6.65% | -16.24% | -38.83% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 59.95% | 27.04% | 6.65% | -16.24% | -38.83% |
| EBIT | 43.69% | 27.15% | 15.13% | -5.01% | -25.64% |
| EBITDA | 34.09% | 23.12% | 14.65% | -2.07% | -19.51% |
| EPS Basic | 39.04% | 9.04% | -8.92% | -25.00% | -40.88% |
| Normalized Basic EPS | 39.87% | 10.41% | -7.91% | -22.88% | -37.84% |
| EPS Diluted | 39.04% | 9.04% | -8.92% | -25.00% | -40.88% |
| Normalized Diluted EPS | 39.87% | 10.41% | -7.91% | -22.88% | -37.84% |
| Average Basic Shares Outstanding | 16.84% | 16.37% | 15.88% | 11.43% | 6.97% |
| Average Diluted Shares Outstanding | 16.84% | 16.37% | 15.88% | 11.43% | 6.97% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |